Ranitidine Market Removal

Ranitidine tablets for the treatment of GERD, heartburn, and ulcers

May 12, 2020  

On April 1, 2020, the FDA announced their request that all manufacturers of ranitidine withdraw all prescription and over the counter (OTC) products from the market immediately. This recall was issued because an unexpected impurity was found in these products that may cause health risks.

What do you need to do?

  • Do not stop taking your medication without speaking with your doctor. The U.S. Food and Drug Administration (FDA) recommends that patients continue taking their medication, as the risk of harm to a patient's health may be higher if the treatment is stopped immediately without any alternative treatment.
  • Please call your doctor right away to obtain a new prescription for another appropriate medication. Your doctor will be able to prescribe another medication for you so you can continue treating your condition without interruption.
  • In light of the current COVID-19 pandemic, the FDA recommends that patients and consumers do not take their medicines to a drug take-back location. Instead, the FDA recommends that you follow the specific disposal instructions in the medication guide or package insert or follow the agency’s recommended steps, which include ways to safely dispose of these medications at home. FDA recommended steps for safe drug disposal at home can be found at www.fda.gov.

For more information or to report any adverse events or quality problems experienced with the use of ranitidine products, please visit the FDA website www.fda.gov.

To report an adverse event to the FDA Med Watch Program:

  • To report by phone, call toll-free: 1.800.FDA (332).1088
  • To fax report, 1.800.FDA(332)0178
  • To report online, visit the FDA website